Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique

Scope & Guideline

Unveiling the Science Behind Nuclear Medicine.

Introduction

Explore the comprehensive scope of Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique in depth and align your research initiatives with current academic trends.
LanguageFrench
ISSN0928-1258
PublisherELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 1993 to 2024
AbbreviationMED NUCL / Med. Nucl.-Imag. Fonct. Metab.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE

Aims and Scopes

The journal 'Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique' focuses on the integration of nuclear medicine and functional imaging techniques to enhance diagnosis, treatment planning, and therapeutic monitoring across various medical conditions, particularly cancers. This journal serves as a platform for disseminating research on innovative imaging modalities, radiopharmaceuticals, and their applications in clinical practice.
  1. Nuclear Medicine Applications:
    The journal covers a wide range of applications of nuclear medicine, including diagnostics, therapeutic interventions, and the development of new radiopharmaceuticals. It emphasizes the use of imaging techniques such as PET, SPECT, and CT in the management of various diseases.
  2. Functional Imaging Techniques:
    A significant focus is placed on advanced imaging modalities and their role in assessing metabolic and physiological processes in diseases, especially cancer. The integration of functional imaging with anatomical imaging enhances the accuracy of diagnosis and treatment evaluation.
  3. Theranostics and Personalized Medicine:
    The journal explores the concept of theranostics, which combines therapeutic and diagnostic approaches, particularly in oncology. This involves the use of targeted radionuclide therapies and personalized treatment plans based on imaging findings.
  4. Emerging Technologies in Imaging:
    Research on novel imaging techniques and technologies, such as digital PET and radiomics, is a core area of interest. The journal discusses advancements that improve imaging quality, quantification, and the ability to predict treatment responses.
  5. Clinical Case Studies and Guidelines:
    The publication includes detailed case studies and clinical practice guidelines that contribute to the understanding of best practices in nuclear medicine and imaging, aiding clinicians in decision-making.
Recent publications in 'Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique' indicate a shift towards emerging themes that reflect current challenges and advancements in nuclear medicine and imaging. These trends suggest a growing interest in integrating new technologies and personalized approaches in clinical practice.
  1. Oncological Imaging Innovations:
    Recent papers show a marked increase in research related to oncological imaging, particularly the use of PET/CT and PET/MR in cancer diagnosis, staging, and treatment response evaluation. This trend highlights the importance of accurate imaging in managing cancer patients.
  2. Theranostic Approaches in Cancer Treatment:
    Emerging themes include the use of theranostic approaches, particularly with PSMA-targeted therapies for prostate cancer. This reflects a broader trend towards combining diagnostics and therapeutics to provide personalized cancer care.
  3. Advanced Imaging Techniques and Radiomics:
    There is a growing interest in advanced imaging techniques and radiomics, which analyze imaging data to predict treatment responses and outcomes. This trend indicates a shift towards quantitative imaging and machine learning applications in nuclear medicine.
  4. Imaging Biomarkers and Prognostic Indicators:
    Recent studies are increasingly focusing on the correlation between imaging biomarkers and clinical outcomes, emphasizing the role of imaging in risk stratification and treatment planning.
  5. Integration of AI and Machine Learning in Imaging:
    The inclusion of artificial intelligence and machine learning in imaging analysis is gaining traction, suggesting a future direction where computational methods enhance diagnostic accuracy and efficiency in nuclear medicine.

Declining or Waning

As the field of nuclear medicine evolves, certain themes have shown a decline in prominence within the journal's publications. These waning scopes may reflect shifts in research focus or advancements in technology that render previous methodologies less relevant.
  1. Traditional Imaging Techniques:
    There is a noticeable decline in the focus on traditional imaging techniques that do not incorporate the advancements of hybrid imaging modalities such as PET/CT or PET/MR. Research in this area has been overshadowed by the increasing relevance of integrated imaging approaches.
  2. General Nuclear Medicine Procedures:
    Publications that discuss general nuclear medicine procedures without specific applications or innovative methodologies have decreased. This suggests a shift towards more specialized and targeted research.
  3. Basic Research on Radiopharmaceuticals:
    While the development of new radiopharmaceuticals remains important, there has been a reduction in basic research papers focused solely on radiopharmaceutical chemistry, as the journal favors studies that demonstrate clinical application and efficacy.
  4. Non-Oncological Applications:
    The focus on non-oncological applications of nuclear medicine, such as cardiology or endocrinology, appears to be waning. The journal is increasingly centered on oncology, particularly in the context of personalized treatment and imaging.

Similar Journals

EUROPEAN RADIOLOGY

Transforming Patient Care Through Cutting-Edge Imaging
Publisher: SPRINGERISSN: 0938-7994Frequency: 12 issues/year

EUROPEAN RADIOLOGY, published by SPRINGER, stands as a prestigious international journal in the field of radiology, nuclear medicine, and imaging, with an impressive impact factor that underscores its significance among peers. With an ISSN of 0938-7994 and an E-ISSN of 1432-1084, this journal provides a platform for cutting-edge research and advancements in medical imaging from 1991 to 2024. Recognized as a Q1 journal in both general Medicine and the specialized Radiology category by 2023, EUROPEAN RADIOLOGY ranks an impressive #17 out of 333 in its field according to Scopus, placing it in the 95th percentile. While it does not currently offer Open Access options, the journal remains essential reading for researchers, professionals, and students striving to stay at the forefront of developments in diagnostic imaging and related technologies. By contributing to a comprehensive understanding of radiological practices, EUROPEAN RADIOLOGY plays a crucial role in shaping the future of medical diagnosis and patient care.

NUCLEAR MEDICINE AND BIOLOGY

Connecting breakthroughs in nuclear medicine with biological insights.
Publisher: ELSEVIER SCIENCE INCISSN: 0969-8051Frequency: 8 issues/year

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

European Journal of Hybrid Imaging

Fostering Collaboration in Hybrid Imaging Excellence
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

European Journal of Hybrid Imaging, published by SpringerNature, stands as a pivotal platform for scholarly discourse in the rapidly evolving fields of hybrid imaging technologies and methodologies. Since its inception in 2017, this open access journal has significantly contributed to the interdisciplinary interface of biophysics, computer science, molecular medicine, and radiology. With its current standing in the Q2 and Q3 quartiles across various categories, it provides valuable insights and research outputs pertinent to both academic and clinical practitioners. The journal's rigorous peer-review process ensures the highest standards of scholarly integrity, while its open access format promotes global accessibility and encourages collaborative research efforts. Covering a diverse range of topics pertinent to hybrid imaging, the journal serves as an essential resource for researchers, professionals, and students alike, fostering innovation and knowledge exchange within the scientific community.

SEMINARS IN NUCLEAR MEDICINE

Bridging research and clinical excellence in nuclear medicine.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0001-2998Frequency: 6 issues/year

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

NUCLEAR MEDICINE REVIEW

Connecting Researchers to Transformative Medical Knowledge
Publisher: VIA MEDICAISSN: 1506-9680Frequency: 2 issues/year

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

ANNALS OF NUCLEAR MEDICINE

Unveiling the Science of Imaging and Treatment
Publisher: SPRINGERISSN: 0914-7187Frequency: 10 issues/year

ANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.

EJNMMI Research

Empowering Research, Transforming Radiology.
Publisher: SPRINGERISSN: 2191-219XFrequency: 1 issue/year

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

PET Clinics

Enhancing Treatment Outcomes through PET Innovations.
Publisher: ELSEVIER INCISSN: 1556-8598Frequency: 4 issues/year

PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.

Imaging

Pioneering Research in Radiology and Beyond
Publisher: AKADEMIAI KIADO ZRTISSN: Frequency: 2 issues/year

Imaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.

CANCER IMAGING

Advancing the Frontiers of Cancer Diagnostics
Publisher: BMCISSN: 1740-5025Frequency: 1 issue/year

CANCER IMAGING, published by BMC, stands as a leading open-access journal in the realms of oncology and medical imaging, significantly contributing to the advancement of cancer research since its inception in 2000. With an impressive impact across multiple domains—most notably ranking Q1 in prestigious categories such as Medicine (miscellaneous), Oncology, and Radiology—this journal ensures high visibility and influence within the academic community. As of 2023, it is recognized in various Scopus rankings, securing top positions in the fields of Radiology, Nuclear Medicine, and Imaging, alongside Radiological and Ultrasound Technology. The journal's commitment to open-access publication, adopted in 2014, enhances accessibility for researchers, healthcare professionals, and students alike, fostering an inclusive environment for sharing critical advancements and innovative methodologies in cancer imaging. Set in the vibrant landscape of the United Kingdom, CANCER IMAGING continues to play a vital role in elucidating the complexities of cancer diagnostics and treatment, establishing itself as an essential resource for those pursuing excellence in cancer care and research.